Last Updated: November 13, 2026

HYDELTRASOL Drug Patent Profile

Name: HYDELTRASOL Drug Patent, Exclusivity, and Generic Launch Dataset
Creator: DrugPatentWatch
License: https://www.drugpatentwatch.com/terms.php

« Back to Dashboard

Which patents cover Hydeltrasol, and what generic alternatives are available?

Hydeltrasol is a drug marketed by Merck and is included in two NDAs.

The generic ingredient in HYDELTRASOL is prednisolone sodium phosphate. There is one drug master file entry for this compound. Eighteen suppliers are listed for this compound. Additional details are available on the prednisolone sodium phosphate profile page.

DrugPatentWatch^® Litigation and Generic Entry Outlook for Hydeltrasol

A generic version of HYDELTRASOL was approved as prednisolone sodium phosphate by BAUSCH AND LOMB INC on July 29^th, 1994.

Start Trial

AI Deep Research

Questions you can ask:

What is the 5 year forecast for HYDELTRASOL?
What are the global sales for HYDELTRASOL?
What is Average Wholesale Price for HYDELTRASOL?

Summary for HYDELTRASOL

US Patents:	0
Applicants:	1
NDAs:	2
Raw Ingredient (Bulk) Api Vendors:	49
Clinical Trials:	10
Patent Applications:	7,366
DailyMed Link:	HYDELTRASOL at DailyMed

Drug patent expirations by year for HYDELTRASOL

Recent Clinical Trials for HYDELTRASOL

Identify potential brand extensions & 505(b)(2) entrants

Sponsor	Phase
Children's Oncology Group	Phase 2
Children's Oncology Group	Phase 1/Phase 2
National Cancer Institute (NCI)	Phase 1/Phase 2

See all HYDELTRASOL clinical trials

US Patents and Regulatory Information for HYDELTRASOL

+ Get email alerts for changes to this table

Glossary

Subscribe to access the full database, or Start Trial
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Merck	HYDELTRASOL	prednisolone sodium phosphate	INJECTABLE;INJECTION	011583-002	Approved Prior to Jan 1, 1982		DISCN	No	No	⤷ Start Trial	⤷ Start Trial				⤷ Start Trial
Merck	HYDELTRASOL	prednisolone sodium phosphate	OINTMENT;OPHTHALMIC, OTIC	011028-001	Approved Prior to Jan 1, 1982		DISCN	No	No	⤷ Start Trial	⤷ Start Trial				⤷ Start Trial
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>TE	>Type	>RLD	>RS	>Patent No.	>Patent Expiration	>Product	>Substance	>Delist Req.	>Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.